Rapid Activation of Akt2 Is Sufficient to Stimulate GLUT4 Translocation in 3T3-L1 Adipocytes  by Ng, Yvonne et al.
Cell Metabolism
Short ArticleRapid Activation of Akt2 Is Sufficient
to Stimulate GLUT4 Translocation
in 3T3-L1 Adipocytes
Yvonne Ng,1 Georg Ramm,1 Jamie A. Lopez,1 and David E. James1,*




in insulin-regulated glucose uptake into muscle and
fat cells by promoting the translocation of glucose
transporter 4 (GLUT4) to the cell surface. However,
it remains unclear whether activation of Akt2 is suffi-
cient since a role for alternate signaling pathways
has been proposed. Here we have engineered 3T3-
L1adipocytes toexpressa rapidly inducibleAkt2 sys-
tembased ondrug-inducible heterodimerization. Ad-
ditionof thedimerizer rapalog resulted in activationof
Akt2 within 5 min, concomitant with phosphorylation
of the Akt substrates AS160 and GSK3. Comparison
with insulin stimulation revealed that the level of
Akt2 activity observed with rapalog was within the
physiological range, reducing the likelihood of off-
target effects. Transient activation of Akt2 also in-
creased glucose transport and GLUT4 translocation
to the plasmamembrane. These results show that ac-
tivation of Akt2 is sufficient to stimulate GLUT4 trans-
location in 3T3-L1 adipocytes to an extent similar to
insulin.
INTRODUCTION
A major physiologic action of insulin is to promote glucose up-
take into muscle and adipose tissue by triggering the transloca-
tion of the facilitative glucose transporter 4 (GLUT4) from intra-
cellular compartments to the cell surface (Bryant et al., 2002).
Defects in this process contribute to the development of insulin
resistance in obesity and type 2 diabetes mellitus.
Insulin stimulation of the phosphatidylinositol 3-kinase (PI3K)/
Akt pathway is necessary for insulin-stimulated glucose trans-
port in both muscle and fat cells. Studies utilizing pharmacologic
inhibitors such as wortmannin (Clarke et al., 1994) and LY294002
(Cheatham et al., 1994), Akt interfering antibodies and Akt sub-
strate peptides (Hill et al., 1999), overexpression of dominant-
negative Akt mutants and ablation of Akt via siRNA (Katome
et al., 2003), and Akt/ mice (Cho et al., 2001) and cell lines
derived from these animals (Bae et al., 2003) have all shown
that activation of Akt is necessary for insulin action. However,
these studies do not exclude the possibility that other signaling
pathways are also required. Indeed, several alternate pathways
including c-Cbl/TC10 (Chiang et al., 2001), atypical protein348 Cell Metabolism 7, 348–356, April 2008 ª2008 Elsevier Inc.kinase C (PKC) z/l (Kotani et al., 1998), and Rac (Khayat et al.,
2000) have been proposed to play an important role in GLUT4
translocation. These pathways are either activated upstream of
Akt as a separate insulin-responsive pathway (c-Cbl/TC10) or di-
verge at the level of PI3K (PKCz/l and Rac). To address the role
of the Akt pathway vis-a`-vis alternate pathways, it is essential to
show that activation of Akt alone is sufficient to mimic the effects
of insulin. Previous studies have shown that overexpression of
constitutively active Akt in 3T3-L1 adipocytes (Kohn et al.,
1996), rat adipocytes (Tanti et al., 1997), and L6 muscle cells
(Hajduch et al., 1998) can trigger GLUT4 translocation. However,
these studies have been criticized because the cells used were
exposed to high levels of activated Akt mutants for long periods
of time prior to analysis, raising the possibility of indirect or non-
physiological effects.
The use of a rapid inducible system that would result in activa-
tion of Akt independently of other pathways would provide
a more rigorous approach to this problem. Roth and colleagues
attempted to achieve this goal by expressing a tamoxifen-induc-
ible Akt construct in 3T3-L1 adipocytes (Kohn et al., 1998). How-
ever, even here, activation of both Akt and GLUT4 translocation
was only observed many hours after tamoxifen stimulation.
These slow responses do not reflect insulin action in vivo, which
occurs within minutes. Moreover, these studies employed the
Akt1 isoform, and it is now clear that Akt2 is the major isoform
involved in insulin action in muscle and fat cells (Cho et al.,
2001; Hill et al., 1999).
To circumvent these problems, we have utilized a previously
described drug-inducible heterodimerization strategy to acutely
activate Akt2 in 3T3-L1 adipocytes. This strategy is based on the
use of rapamycin to heterodimerize the rapamycin-binding do-
main of the FK506-binding protein 12 (FKBP12) and a 93 amino
acid domain from FRAP/mTOR called FRB (FRAP rapamycin-
binding domain). A nonimmunosuppressive analog of rapamy-
cin, known as rapalog (AP21967), has been developed to bind
with high affinity to modified FRB containing a single amino
acid change (Thr2098Leu) but not to endogenous mTOR. There-
fore, addition of rapalog to cells expressing a myristoylated
FKBP12 fragment and an FRB-Akt chimera induces rapid trans-
location of FRB-Akt to the plasma membrane, mimicking the
effect of PI3K-induced translocation. This system has been used
to study regulation of Akt activation (Scheid et al., 2002) and
apoptosis (Li et al., 2002). This approach allows for a more phys-
iological analysis, as it provides rapid activation of Akt2, avoiding
the potential indirect consequences of long-term activation. It
also bypasses potential upstream signaling pathways normally
induced by insulin, allowing direct study of Akt2-regulated
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Akt2 Is Sufficient for GLUT4 TranslocationFigure 1. Development of a Rapalog-Inducible System for Regulated Akt2 Activation
(A) Schematic representation of chimeric constructs used in this study.
(B) Model of cell-permeable rapalog (AP21967)-mediated activation of FRB-Akt2 by crosslinking the FRB and FKBP domains, bringing the FRB-Akt2 fusion
protein to the plasma membrane for its phosphorylation.
(C) Expression and localization of FRB-Akt2-Myc and Myr-FKBPWT-V5 or Myr-FKBP A2-V5 fusion proteins in 3T3-L1 adipocytes. Cells were labeled for immu-
nofluorescence with anti-Myc or V5 antibodies followed by Cy2- and Cy3-conjugated secondary antibodies, respectively. Scale bar = 40 mM.
(D) SDS lysates of 3T3-L1 adipocytes expressing the control empty vector or FRB-Akt2-Myc and Myr-FKBP WT-V5 or Myr-FKBP A2-V5 lentivirus.cellular processes in the absence of insulin. We took advantage
of the lentivirus-mediated gene transfer technique to efficiently
express transgenes in 3T3-L1 adipocytes. Akt2 was rapidly acti-
vated following addition of the dimerizer rapalog, and this activa-
tion was accompanied by robust phosphorylation of a range of
Akt substrates as well as increased GLUT4 translocation and
glucose transport.
RESULTS AND DISCUSSION
A System to Study Rapid Activation of Akt2
in 3T3-L1 Adipocytes
To acutely regulate the activity of Akt in 3T3-L1 adipocytes, we
employed a drug-inducible heterodimerization system devel-
oped by ARIAD Pharmaceuticals. Full-length Akt2 was fused
in-frame with the rapamycin-binding domain FRB (a mutated
fragment from human FRAP/mTOR) to generate FRB-Akt2 (see
Figure 1A). To effect membrane recruitment, a construct
containing two copies of FKBP12with aSrcmyristoylation signal
sequence at its amino terminus (FKBP WT) was generated
(Figure 1A). In the presence of rapalog, a synthetic lipid-perme-
able nonbioactive drug, the two fusion proteins heterodimerize,
recruiting FRB-Akt2 to the plasmamembrane (Figure 1B). A con-
trol construct in which the myristoylated glycine at the second
amino acid position was converted to alanine to eliminate the
membrane-targeting function of the Src myristoylation signal
sequence (FKBP A2) was also created (Figure 1A).
We explored a number of expression systems to fulfill the fol-
lowing criteria: FRB-Akt2 expression and Akt activation levels
preferably within the range observed for endogenous Akt, to
avoid off-target effects; maintenance of insulin responsiveness;
and maximum efficiency of expression of both fusion proteinsin 3T3-L1 adipocytes, thus facilitating metabolic studies in intact
cells. We found that the lentiviral systemwas the only expression
system that fulfilled these criteria. Infection of 3T3-L1 adipocytes
with lentivirus expressing both FRB-Akt2 and FKBP WT or the
FKBP A2 mutant resulted in >90% transduction (Figure 1C).
Moreover, expression of these fusion proteins in 3T3-L1 adipo-
cytes did not have any detectable toxic effects, nor did it modify
the insulin responsiveness of the cells (data not shown), although
we did observe a significant increase in cell size following lenti-
viral infection. However, this effect was Akt independent. The
expression of fusion proteins was readily detected 3 days after
transduction and remained stable for many weeks. The expres-
sion level of FRB-Akt2 was comparable to that of endogenous
Akt. FKBP WT and the FKBP A2 mutant were also expressed
at similar levels in 3T3-L1 adipocytes (Figure 1D).
Rapid Insulin-Independent Activation of FRB-Akt2
and Akt Substrates
We first examined the dose dependence of FRB-Akt2 activation
by rapalog in 3T3-L1 adipocytes. Phosphorylation of FRB-Akt2
at Thr308 and Ser473 was observed using 20 nM rapalog, and
the level of phosphorylation at both sites plateaued at 200–
500 nM (Figure 2A). Importantly, we did not observe any signifi-
cant phosphorylation of endogenous Akt in response to rapalog,
nordidweobservephosphorylationof FRB-Akt2 in cells express-
ing the FKBP A2 mutant (Figure 2A). A similar dose-response
curve for the phosphorylation of several downstream substrates
of Akt was also observed in response to rapalog (Figure 2B).
These data indicate that inducible recruitment of FRB-Akt2 to
the plasma membrane in 3T3-L1 adipocytes is sufficient to acti-
vate Akt2 kinase activity, recapitulating the physiological actions
of this kinase on a range of downstream substrates.Cell Metabolism 7, 348–356, April 2008 ª2008 Elsevier Inc. 349
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Akt2 Is Sufficient for GLUT4 TranslocationFigure 3. Rapalog-Induced Activation of FRB-Akt2 Is Independent of Insulin Receptor Signaling in 3T3-L1 Adipocytes
(A) IRb, IRS-1, and MAPK are not activated by Akt2. 3T3-L1 adipocytes transduced with the respective lentivirus were serum starved for 2 hr and stimulated with
10 nM insulin or 500 nM rapalog for the indicated times. Cell lysates were prepared and tyrosine-phosphorylated proteins were immunoprecipitated with anti-
phosphotyrosine antibody (4G10). The immune complexes were then immunoblotted with anti-IRb or anti-IRS-1 antibodies. Total cell lysates (TCL) were also
immunoblotted for total IRb, total IRS-1, pMAPK, and pAkt Ser473. Immunoblots shown are from a representative experiment (n = 3).
(B) Activation of FRB-Akt2 is independent of PI3K. 3T3-L1 adipocytes transduced with the respective lentivirus were serum starved for 2 hr and stimulated with
100 nMwortmannin or vehicle (DMSO, final concentration 0.1%) for 30min before stimulation with or without 10 nM insulin or 500 nM rapalog for 30min. Total cell
lysates were immunoblotted with antibodies directed against pAkt Thr308, pAkt Ser473, total Akt, pAS160 Thr642, or total AS160. Immunoblots shown are from
a representative experiment (n = 3).We next examined the kinetics of FRB-Akt2 activation in re-
sponse to rapalog. Significant phosphorylation of FRB-Akt2 at
Thr308 and Ser473 was observed 5min after addition of rapalog,
reaching a plateau by 15 min (Figure 2C). For comparison, we
also examined insulin-stimulated phosphorylation of endoge-
nous Akt in parallel. Importantly, the level of rapalog-induced
phosphorylation of FRB-Akt2 at Ser473 was similar to insulin-
stimulated phosphorylation of endogenous Akt at 10 nM insulin
(Figure 2C). Notably, rapalog-induced phosphorylation at
Thr308 was significantly less than insulin-stimulated (10 nM)
phosphorylation of endogenous Akt at the same site. However,
this likely reflects the differential affinity of these antibodies for
Akt1 versus Akt2, both isoforms being expressed in 3T3-L1 ad-
ipocytes (Hill et al., 1999). Using phospho-Akt substrate (PAS)
antibody, addition of rapalog to 3T3-L1 adipocytes triggered
the phosphorylation of a range of downstream substrates similar
to that observed with insulin (Figure 2D). We also observed rapid
phosphorylation ofGSK3, S6 kinase (S6K), andAS160, a recently
identified substrate of Akt (Sano et al., 2003), at two separate Akt
phosphorylation sites following rapalog addition, although the
phosphorylation of Thr389 in S6K and Ser588 in AS160 wasslower than that of either Ser9 in GSK3b or Thr642 in AS160
(Figure 2E). Moreover, whereas the amplitude of AS160 phos-
phorylation was similar to that observed with 10 nM insulin,
this was not the case for either S6K or GSK3 (Figure 2E). This
may reflect differential subcellular targeting of these substrates
with respect to the FRB-Akt2 construct or a differential role for
Akt1 versus Akt2 in signaling to its selective substrates. We
also performed similar comparative studies using a more physi-
ological dose of insulin (1 nM; James et al., 1985) in which we
also obtained similar activation of Akt and AS160 phosphoryla-
tion (see Figure S1 available online). One other discrepancy high-
lighted by these studies was the spareness in signaling. At 1 nM
insulin, we observed that endogenous Akt phosphorylation was
barely detectable whereas AS160 phosphorylation at Thr642
was similar to that observed at 10 nM insulin (Figures 2C and 2E).
Rapalog-Induced Activation of FRB-Akt2 Is Independent
of Insulin Receptor Signaling
Rapalog addition to 3T3-L1 adipocytes specifically activated the
Akt pathway independently of the insulin receptor (Figure 3A).
We were unable to detect significant tyrosine phosphorylationFigure 2. Rapalog-Induced Activation of FRB-Akt2 and Akt2 Downstream Signaling
(A and B) Dose-dependent activation of FRB-Akt2 and Akt2 downstream signaling. 3T3-L1 adipocytes transduced with the indicated lentivirus were serum
starved for 2 hr and treated with different concentrations of rapalog (AP21967) for 15 min. Total cell lysates were immunoblotted with antibodies raised against
phospho-Akt (pAkt) Thr308, pAkt Ser473, and the Myc and V5 epitopes (A) or pGSK3 a/b Ser21/9, pS6K Thr389, 14-3-3b, pAS160 Thr642, and total AS160 (B).
(C–E) Time course of FRB-Akt2 activation and Akt2 downstream signaling. 3T3-L1 adipocytes were stimulated with 500 nM rapalog or 1 nM or 10 nM insulin for
the indicated times. Total cell lysates were immunoblotted with antibodies directed against pAkt Thr308, pAkt Ser473, total Akt, and theMyc and V5 epitopes (C);
phospho-Akt substrate (PAS) (D); or pGSK3b Ser9, pS6K Thr389, 14-3-3b, pAS160 Ser588, pAS160 Thr642, and total AS160 (E).
Data are presented as means ± SD. *p < 0.05, **p < 0.01 versus no treatment, or as indicated, by Student’s t test (n = 3).Cell Metabolism 7, 348–356, April 2008 ª2008 Elsevier Inc. 351
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Akt2 Is Sufficient for GLUT4 TranslocationFigure 4. Rapalog-Induced GLUT4 and IRAP Translocation and Glucose Uptake in 3T3-L1 Adipocytes
(A) 3T3-L1 adipocytes expressing HA-GLUT4 were transduced with the respective lentivirus and serum starved for 2 hr before stimulation with 1 nM or 10 nM
insulin for 20 min or 500 nM rapalog for 30 min. The amount of HA-GLUT4 at the plasma membrane was determined by labeling with anti-HA antibody in com-
bination with Cy3-conjugated secondary antibody in nonpermeabilized cells. Cells were then permeabilized, and cells transduced with FRB-Akt2-Myc lentivirus
were detected with anti-Myc followed by Cy2-conjugated secondary antibody. Images are from a representative experiment (n = 3). Scale bar = 40 mM.
(B) HA-GLUT4-expressing 3T3-L1 adipocytes grown in 96-well plates were transduced with lentivirus and stimulated for the indicated periods with 10 nM insulin
or 500 nM rapalog. The amount of HA-GLUT4 at the plasma membrane was determined by anti-HA fluorescence immunolabeling of nonpermeabilized cells and
expressed as a percentage of total cellular HA-GLUT4 as determined by labeling of permeabilized cells. Data are presented as means ± SD. *p < 0.05, **p < 0.01
versus no treatment by Student’s t test (n = 3).
(C) Tf-IRAP-expressing 3T3-L1 adipocytes transduced with lentivirus were stimulated with 10 nM insulin or 500 nM rapalog for 30 min. Surface Tf-IRAP was
analyzed by labeling with Alexa 488-Tf. Scale bar = 20 mM.352 Cell Metabolism 7, 348–356, April 2008 ª2008 Elsevier Inc.
Cell Metabolism
Akt2 Is Sufficient for GLUT4 Translocationof the insulin receptor (IRb) or insulin receptor substrate-1 (IRS-1)
in response to rapalog in 3T3-L1 adipocytes expressing FRB-
Akt2 and FKBP WT. In addition, we were unable to detect any
significant activation of the mitogen-activated protein kinase
(MAPK) pathway in response to rapalog, which is activated in
response to insulin in an Akt-independent manner. Furthermore,
in the presence of the PI3K inhibitor wortmannin, rapalog-stimu-
lated phosphorylation of Akt and AS160 was not inhibited
(Figure 3B).
Activation of FRB-Akt2 Stimulates GLUT4 and IRAP
Translocation andGlucose Uptake in 3T3-L1 Adipocytes
The above studies suggest that the dimerization system can be
adapted to 3T3-L1 adipocytes to study the specific function of
Akt2 in these cells under physiological conditions in terms of
both the kinetics and amplitude of Akt activation. Hence, we
next asked whether induced activation of Akt2 was sufficient
to stimulate HA-GLUT4 translocation as described previously
(Govers et al., 2004) and glucose transport in 3T3-L1 adipocytes.
In unstimulated 3T3-L1 adipocytes transduced with an empty
lentivirus, HA-GLUT4 was predominantly retained within cells.
A significant redistribution of this reporter to the cell surface
was observed in response to either 1 nM or 10 nM insulin (Fig-
ure 4A). Strikingly, a similar level of HA-GLUT4 translocation to
the cell surface was observed in response to rapalog in 3T3-L1
adipocytes expressing FRB-Akt2 and FKBP WT (Figures 4A
and 4B). Conversely, no significant HA-GLUT4 translocation
was observed in response to rapalog in cells expressing FRB-
Akt2 and the FKBP A2 mutant (Figures 4A and 4B). To confirm
that these effects were not specific to GLUT4, we also showed
that rapalog stimulated the translocation of the insulin-regulated
aminopeptidase (IRAP) reporter transferrin receptor-IRAP
(Tf-IRAP) to the plasmamembrane in amanner similar to that ob-
served with insulin (Figure 4C; Gonzalez and McGraw, 2006).
The time course of rapalog-stimulated GLUT4 translocation
was slightly delayed compared to insulin (Figure 4B), but this par-
alleled Akt activation (Figure 2C). In contrast to the observations
with insulin, rapalog-stimulated GLUT4 translocation was unaf-
fected by the PI3K inhibitor wortmannin (Figure S2).
We next examined the effect of rapalog on glucose transport in
3T3-L1 adipocytes. Incubation of 3T3-L1 adipocytes that were
transduced with control lentivirus with 1 nM or 10 nM insulin
resulted in an increase in 2-deoxyglucose uptake by 8.5- and
9.5-fold, respectively (Figure 4D). Intriguingly, the dose re-
sponse of insulin-stimulated 2-deoxyglucose uptake paralleled
the dose-response activation of AS160 phosphorylation, but
not that of Akt itself (Figures 2C and 2E). Hence, these data con-
firm thatminimal activation of Akt is sufficient to elicit amaximum
effect on glucose transport and AS160 phosphorylation. With re-
gard to the latter, it is noteworthy that we did not measure the
amount of nonphosphorylated AS160 under these conditions,
and so it remains unclear whether the total AS160 pool is phos-
phorylated in response tomaximal stimulation. Hence, it remains
possible that the discrete subcellular distribution of activated Akt
to a pool of AS160 that has to be inactivated in order to allow
GLUT4 translocationmay play an important role. This may be rel-evant in light of recent studies that found an incomplete inhibitory
effect of Akt inhibition on GLUT4 translocation (Gonzalez and
McGraw, 2006; Jiang et al., 2003). Infection of 3T3-L1 adipo-
cytes with FRB-Akt2 and FKBP lentivirus had no significant ef-
fect on basal 2-deoxyglucose uptake (Figure 4D). Rapalog stim-
ulation of 3T3-L1 adipocytes expressing FRB-Akt2 and the
FKBP A2 mutant did not result in any significant increase in glu-
cose uptake at any time tested (Figure 4D), consistent with
the lack of activation of Akt2 and HA-GLUT4 translocation
(Figure 2C; Figure 4B). Exposure of cells expressing FRB-Akt2
and FKBP WT to 500 nM rapalog for 15 min resulted in an
4.5-fold increase in glucose uptake, which was maintained
after 30 min and 45 min of stimulation (Figure 4D). Interestingly,
in contrast to AS160 phosphorylation (Figure 2E) and HA-GLUT4
translocation (Figure 4B), rapalog-stimulated 2-deoxyglucose
uptake was less than that observed with insulin. It is unlikely
that this is due to the inability of rapalog to stimulate GLUT1
translocation. In contrast to previous studies (Foran et al.,
1999), we observed that insulin-stimulated GLUT1 translocation
was inhibited by wortmannin and an Akt inhibitor (Figure S3) in
agreement with studies in Akt2 knockout mice (Bae et al.,
2003). Perhaps a more likely scenario is that the Akt-dependent
movement of GLUT4 to the plasma membrane may not be suffi-
cient for full transport activation, implicating an additional step in
this process (Hausdorff et al., 1999).
These data support the notion that rapid activation of Akt2 is
sufficient to stimulate GLUT4 translocation in 3T3-L1 adipo-
cytes. We also observed no additivity between rapalog and insu-
lin on glucose transport (Figure S4), indicating that these agents
likely trigger GLUT4 translocation via the same mechanism. The
inducible system employed was designed to replicate the phys-
iological effects of insulin in terms of kinetics and amplitude of
the Akt response. This would place glucose transport in line
with many other metabolic actions of insulin including glycogen
synthesis, protein synthesis, and lipogenesis that also appear to
rely principally upon Akt for their activation (Whiteman et al.,
2002). Hence, this positions Akt at a major node in the regulation
of metabolism by insulin.
Several other signaling pathways have been implicated in in-
sulin-regulated glucose transport. One of these is the PI3K-inde-
pendent c-Cbl/TC10/CIP4/2 pathway, which has been sug-
gested to operate in parallel to the PI3K/Akt pathway (Chiang
et al., 2001). However, other studies have not been able to
show an inhibition of insulin-stimulated glucose transport using
siRNA knockdown of various members of the pathway (Mitra
et al., 2004) or in c-Cbl/ mice (Molero et al., 2004). In addition,
PI3K-dependent activation of Ral A and the exocyst complex
have been implicated in targeting GLUT4 vesicles to the cell sur-
face (Chen et al., 2007). More recently, an important role for the
atypical PKCl in insulin-stimulated glucose uptake has been
suggested. Muscle-specific deletion of PKCl results in a pro-
found inhibition of insulin-stimulated glucose transport into mus-
cle without any apparent defect in insulin-stimulated Akt activa-
tion (Farese et al., 2007). The relevance of these observations
with respect to the present study remains to be defined. One
possibility is that in addition to Akt activation, only a basal level(D) 3T3-L1 adipocytes transduced with lentivirus were stimulated with 500 nM rapalog or 1 nM or 10 nM insulin for the indicated times, and 2-[3H]deoxyglucose
uptake was determined. Data are presented as means ± SD. **p < 0.01 versus no treatment by Student’s t test (n = 3).Cell Metabolism 7, 348–356, April 2008 ª2008 Elsevier Inc. 353
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location. Notably, many of these studies have relied on the use of
inhibitors that block insulin action, whereas the use of inducible
systems for studying the effects of rapid activation of these sig-
naling molecules on GLUT4 translocation has yet to be reported.
The observation that activation of Akt is sufficient to stimulate
GLUT4 translocation suggests that identification of additional
Akt substrates in adipocytes will be fruitful. However, recent
functional studies in adipocytes suggest that the Akt substrate
Rab GTPase-activating protein AS160 may not be the only reg-
ulated target of insulin (Bai et al., 2007; Gonzalez and McGraw,
2006). Based on the present study, we suggest that there may
be alternate substrates of Akt that play an important role in this
process, and so the present study lays the groundwork for future
studies in this area.
EXPERIMENTAL PROCEDURES
Construction of Lentiviral Vectors
The ARGENT Regulated Transcription Retrovirus Kit (version 2.0) was ob-
tained from ARIAD Pharmaceuticals. The cDNA encoding the full-length hu-
man Akt2 was amplified by polymerase chain reaction (PCR) with a 30 primer
containing the Myc epitope tag and then cloned into pC4-RHE vector (ARIAD)
in-frame with the rapamycin-binding domain FRB to produce FRB-Akt2-Myc.
To generate the lentiviral expression vector, the resulting FRB-Akt2-Myc was
subcloned into the lentiviral vector pRRL-PGK. The myristoylated rapamycin-
binding domains were generated by PCR amplification of the rapamycin-bind-
ing domains (FKBP12) from pC4M-F2E vector (ARIAD) using a 3
0 primer con-
taining the V5 epitope tag and subcloned into a separate pRRL-PGK lentiviral
vector (FKBPWT). A negative control construct (FKBP A2) was created by site-
directed mutagenesis changing the glycine at the amino acid position 2 of the
Src myristoylation sequence to alanine. The plasmids were verified by PCR
sequencing. The pRRL-PGK lentiviral expression vector was generously pro-
vided by R. Hoeben (Leiden University Medical Center, The Netherlands), and
the packaging vectors pMDLg/pRRE (gag/pol vector), pRSV-Rev (rev vector),
and pMD2.G (VSV-G vector) were from D. Trono (Ecole Polytechnique Fe´de´r-
ale de Lausanne, Switzerland).
Cell Culture and Lentiviral Infection
3T3-L1 fibroblasts (ATCC) were cultured and differentiated into adipocytes as
described previously (Larance et al., 2005). 3T3-L1 fibroblasts were infected
with pBabepuro-HA-GLUT4 or pBabepuro-HA-GLUT1 retrovirus as described
previously (Shewan et al., 2003). Recombinant lentiviruses were produced by
cotransfecting HEK293 FT cells (Invitrogen) with lentiviral expression and
packaging plasmids using the calcium phosphate transfection method as
described previously (Carlotti et al., 2004; Li and Rossi, 2005). Infectious len-
tiviruses were harvested at 24 and 48 hr posttransfection and centrifuged at
1620 3 g for 10 min. The supernatant collected was concentrated 10-fold us-
ing Amicon Ultracel concentration tubes (100 kDa pore size; Millipore). 3T3-L1
adipocytes at day 5 of differentiation were infected with 50 ml/well (for 96-well
plate), 200 ml/well (for 24-well plate), or 960 ml/well (for 6-well plate) of concen-
trated empty vector or FRB-Akt2 lentivirus containing 4 mg/ml of polybrene. Af-
ter 16–24 hr, the concentrated lentivirus was removed and replaced with fresh
culture medium. For 3T3-L1 adipocytes requiring double infection, cells were
infected again with either concentrated FKBP WT or FKBP A2 lentivirus.
Experiments were performed at 5 days posttransduction.
Immunoprecipitation and Western Blot Analysis
After treatments, cells were washed twice with ice-cold PBS and solubilized in
2% SDS in PBS with phosphatase inhibitors (1 mM sodium pyrophosphate,
2mMsodium vanadate, 10mMsodium fluoride) andComplete protease inhib-
itor mixture (Roche). Insoluble material was removed by centrifugation at
18,000 3 g for 10 min, and proteins were then separated by SDS-PAGE and
transferred to polyvinylidene difluoride membranes (Millipore). Membranes
were incubated in blocking buffer (BB) containing 5% BSA in 0.1% Tween354 Cell Metabolism 7, 348–356, April 2008 ª2008 Elsevier Inc.20 in Tris-buffered saline and immunoblotted with respective antibodies over-
night at 4C in BB. After incubation, membranes were washed and incubated
with horseradish peroxidase-labeled secondary antibodies (Amersham) and
then detected by SuperSignal West Pico chemiluminescent substrate (Pierce).
In some cases, IR dye 700- or 800-conjugated secondary antibodies (Rock-
land Immunochemicals) were used. Membranes were then scanned in the
700 nM or 800 nM channel using an Odyssey IR imager. Quantification of
protein levels was performed using Odyssey IR imaging system software.
For immunoprecipitation, cells after treatments were subsequently washed
twice with ice-cold PBS before solubilization for 20 min at 4C in RIPA buffer
(50 mM Tris [pH 7.5], 150mMNaCl, 1% Triton X-100, 0.5% sodium deoxycho-
late, 0.1% SDS, 1 mM EDTA, 10% glycerol) with phosphatase inhibitors and
Complete protease inhibitor mixture. Lysates obtained after centrifugation at
18,000 3 g for 20 min were incubated with 2 mg of anti-phosphotyrosine anti-
body or nonimmunized mouse IgG overnight at 4C. The antibodies were then
captured with protein G Sepharose beads (Pierce) for 2 hr, and immunoprecip-
itates were washed extensively with ice-cold RIPA buffer and boiled in SDS
sample buffer.
2-Deoxyglucose Uptake
2-deoxyglucose uptake into 3T3-L1 adipocytes was performed as described
previously (van Dam et al., 2005).
Immunofluorescence Microscopy
For detection of double infection, 3T3-L1 adipocytes were permeabilized and
immunolabeled with polyclonal Myc antibody and monoclonal V5 antibody to
detect FRB-Akt2-Myc and Myr-FKBP WT-V5 or Myr-FKBP A2-V5, respec-
tively. Primary antibodies were detected with anti-rabbit Cy2- and anti-mouse
Cy3-conjugated secondary antibodies. To determine HA-GLUT4 surface la-
beling, cells after treatments were washed in ice-cold PBS, fixed, and immu-
nolabeled for surface HA-GLUT4 using monoclonal HA antibody. Cells were
then permeabilized with saponin and immunolabeled with polyclonal anti-
Myc antibody to identify cells infected with FRB-Akt2-Myc. Primary antibodies
were detected with anti-mouse Cy3- and anti-rabbit Cy2-conjugated second-
ary antibodies. Optical sections were obtained through sequential scans for
Cy2 (excitation 488 nm) and Cy3 (excitation 543 nm) using a Leica DM IRE2
TCS SP2 AOBS confocal laser scanning microscope with a 633 NA/1.32 CS
oil HCX PL APO objective.
Quantitative GLUT4 Translocation Assay
HA-GLUT4 translocation to the plasma membrane was measured as de-
scribed previously (Govers et al., 2004). Briefly, lentivirally infected 3T3-L1 ad-
ipocytes stably expressing HA-GLUT4 in 96-well plates were starved for 2 hr in
serum- and bicarbonate-free DMEM containing 20 mM HEPES (pH 7.4) and
0.2% BSA. After stimulation, cells were fixed and immunolabeled with mono-
clonal anti-HA antibody followed by Alexa 488-labeled secondary antibody in
the absence or presence of saponin to analyze the amount of HA-GLUT4 at the
plasma membrane or the total HA-GLUT4 content, respectively.
Tf-IRAP Translocation Measured by Fluorescence Microscopy
Lentivirally infected 3T3-L1 adipocytes stably expressing a Tf-IRAP chimera
(Lampson et al., 2000) were stimulated with either rapalog or insulin. Cells
were washed with ice-cold DMEM, incubated with Alexa 488-Tf for 1 hr in
DMEM with 20 mM HEPES (pH 7.4) and 0.2% BSA at 4C, and then fixed in
paraformaldehyde. Images were collected and processed as above.
Statistical Analysis
Data are expressed as means ± standard deviation (SD). p values were calcu-
lated by two tailed Student’s t test using Microsoft Excel.
SUPPLEMENTAL DATA
Supplemental Data include four figures and can be foundwith this article online
at http://www.cellmetabolism.org/cgi/content/full/7/4/348/DC1/.
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